Partha Nandy

1.2k total citations
45 papers, 950 citations indexed

About

Partha Nandy is a scholar working on Pharmacology, Psychiatry and Mental health and Statistics and Probability. According to data from OpenAlex, Partha Nandy has authored 45 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Psychiatry and Mental health and 6 papers in Statistics and Probability. Recurrent topics in Partha Nandy's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Statistical Methods in Clinical Trials (5 papers) and Prostate Cancer Treatment and Research (5 papers). Partha Nandy is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Statistical Methods in Clinical Trials (5 papers) and Prostate Cancer Treatment and Research (5 papers). Partha Nandy collaborates with scholars based in United States, Belgium and Canada. Partha Nandy's co-authors include Mahesh N. Samtani, Dan J. Kopacz, Craig Landau, Peter G. Lacouture, Danlin Wu, An Vermeulen, Xu Steven Xu, Ruth Swanton, Adrian Dunne and Kim Stuyckens and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Partha Nandy

43 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Partha Nandy United States	18	249	215	133	130	128	45	950
Michael J. Fossler United States	22	255 1.0×	153 0.7×	135 1.0×	150 1.2×	85 0.7×	69	1.5k
Sunny Chapel United States	16	134 0.5×	128 0.6×	193 1.5×	107 0.8×	164 1.3×	45	991
Anup Majumdar United States	20	538 2.2×	388 1.8×	226 1.7×	156 1.2×	84 0.7×	49	1.3k
Minkyung Oh South Korea	19	319 1.3×	76 0.4×	67 0.5×	66 0.5×	112 0.9×	94	1.2k
Marc R. Gastonguay United States	21	158 0.6×	266 1.2×	124 0.9×	119 0.9×	95 0.7×	78	1.6k
Pyry A. J. Välitalo Netherlands	18	108 0.4×	243 1.1×	75 0.6×	176 1.4×	85 0.7×	33	860
C Aguirre Spain	18	87 0.3×	137 0.6×	67 0.5×	59 0.5×	140 1.1×	55	846
Samer Mouksassi United States	15	110 0.4×	207 1.0×	115 0.9×	61 0.5×	33 0.3×	37	974
Deborah Panebianco United States	22	351 1.4×	68 0.3×	143 1.1×	89 0.7×	206 1.6×	64	1.4k
Dolores Ochoa Spain	25	111 0.4×	198 0.9×	176 1.3×	67 0.5×	301 2.4×	98	1.6k

Countries citing papers authored by Partha Nandy

Since Specialization

Citations

This map shows the geographic impact of Partha Nandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Partha Nandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Partha Nandy more than expected).

Fields of papers citing papers by Partha Nandy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Partha Nandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Partha Nandy. The network helps show where Partha Nandy may publish in the future.

Co-authorship network of co-authors of Partha Nandy

This figure shows the co-authorship network connecting the top 25 collaborators of Partha Nandy. A scholar is included among the top collaborators of Partha Nandy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Partha Nandy. Partha Nandy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Cheng, et al.. (2025). Population Pharmacokinetic/Pharmacodynamic and Exposure–Response Modeling of Garadacimab in Healthy Volunteers and Patients With Hereditary Angioedema. CPT Pharmacometrics & Systems Pharmacology. 14(5). 954–963.

T’jollyn, Huybrecht, Alberto Russu, Raja Venkatasubramanian, et al.. (2024). Model-Informed Clinical Development of Once-Every-6-Month Injection of Paliperidone Palmitate in Patients with Schizophrenia: A Pharmacometric Bridging Approach (Part I). European Journal of Drug Metabolism and Pharmacokinetics. 49(4). 477–489. 1 indexed citations

T’jollyn, Huybrecht, Raja Venkatasubramanian, Srihari Gopal, et al.. (2024). Model-Informed Clinical Development of 6-Monthly Injection of Paliperidone Palmitate in Patients with Schizophrenia: Dosing Strategies Guided by Population Pharmacokinetic Modeling and Simulation (Part II). European Journal of Drug Metabolism and Pharmacokinetics. 49(4). 491–506. 3 indexed citations

Zhu, Peijuan, Chyi‐Hung Hsu, Chuanpu Hu, et al.. (2020). Application of Trial Simulation in the Design of a Prospective Study for Concentration-QTc Analysis in Support of a Thorough QT Study Waiver. The AAPS Journal. 22(5). 101–101. 1 indexed citations

Zhang, Liping, Xiaoyu Yan, Keith A.A. Fox, et al.. (2020). Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation. Journal of Thrombosis and Thrombolysis. 50(1). 20–29. 15 indexed citations

Rossenu, Stefaan, Peter Zannikos, Partha Nandy, et al.. (2020). Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression. Clinical Pharmacokinetics. 60(4). 501–516. 43 indexed citations

Ark, Peter van der, Georg Golor, Luc Van Nueten, Partha Nandy, & Peter de Boer. (2018). Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects. Journal of Psychopharmacology. 32(12). 1330–1340. 16 indexed citations

Huntjens, Dymphy, et al.. (2016). Population Pharmacokinetic Modeling of Tapentadol Extended Release (ER) in Healthy Subjects and Patients with Moderate or Severe Chronic Pain. Clinical Drug Investigation. 36(3). 213–223. 8 indexed citations

Ryan, Charles J., Kim Stuyckens, Matthew R. Smith, et al.. (2015). Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate–Treated Castration-Resistant Prostate Cancer Patients. Clinical Cancer Research. 21(14). 3170–3177. 50 indexed citations

10.

Samtani, Mahesh N., Nandini Raghavan, Gerald Novak, Partha Nandy, & Vaibhav A. Narayan. (2014). Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative. Neuropsychiatric Disease and Treatment. 10. 929–929. 46 indexed citations

11.

Samtani, Mahesh N., Xu Steven Xu, Adrian Dunne, et al.. (2013). Modeling continuous bounded outcome scores using beta regression with NONMEM (R) VII. Journal of Pharmacokinetics and Pharmacodynamics. 40. 1 indexed citations

12.

Xu, Xu Steven, Mahesh N. Samtani, Adrian Dunne, et al.. (2013). Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries. Journal of Pharmacokinetics and Pharmacodynamics. 40(4). 537–544. 17 indexed citations

13.

Xu, Xu Steven, et al.. (2012). Pharmacokinetic and Pharmacodynamic Modeling of Opioid-Induced Gastrointestinal Side Effects in Patients Receiving Tapentadol IR and Oxycodone IR. Pharmaceutical Research. 29(9). 2555–2564. 18 indexed citations

14.

Xu, Xu Steven, Adrian Dunne, Holly Kimko, Partha Nandy, & An Vermeulen. (2011). Impact of low percentage of data below the quantification limit on parameter estimates of pharmacokinetic models. Journal of Pharmacokinetics and Pharmacodynamics. 38(4). 423–432. 32 indexed citations

15.

Dunne, Adrian, Mila Etropolski, An Vermeulen, & Partha Nandy. (2011). On Average: Data Exploration Based on Means Can Be Misleading. The AAPS Journal. 14(1). 60–67. 2 indexed citations

16.

Nandy, Partha, et al.. (2010). Population Pharmacokinetics of Doripenem Based on Data from Phase 1 Studies with Healthy Volunteers and Phase 2 and 3 Studies with Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 54(6). 2354–2359. 42 indexed citations

17.

Xu, Xu Steven, et al.. (2010). Population Pharmacokinetics of Tapentadol Immediate Release (IR) in Healthy Subjects and Patients with Moderate or Severe Pain. Clinical Pharmacokinetics. 49(10). 671–682. 25 indexed citations

18.

Girgis, Ihab, Partha Nandy, Jeffrey S. Nye, et al.. (2010). Pharmacokinetic–pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age. Epilepsia. 51(10). 1954–1962. 33 indexed citations

19.

Kopacz, Dan J., Christopher M. Bernards, Hugh W. Allen, et al.. (2003). A Model to Evaluate the Pharmacokinetic and Pharmacodynamic Variables of Extended-Release Products Using In Vivo Tissue Microdialysis in Humans: Bupivacaine-Loaded Microcapsules. Anesthesia & Analgesia. 97(1). 124–131. 36 indexed citations

20.

Kopacz, Dan J., Peter G. Lacouture, Danlin Wu, et al.. (2003). The Dose Response and Effects of Dexamethasone on Bupivacaine Microcapsules for Intercostal Blockade (T9 to T11) in Healthy Volunteers. Anesthesia & Analgesia. 96(2). 576–582. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact